Exo-Net Pan-Exosome Capture Beads Tender, USA - 104486125

Procurement Summary

Country : USA

Summary : Exo-Net Pan-Exosome Capture Beads

Deadline : 29 Jul 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 104486125

Document Ref. No. : SS-NIAID-24-2232555

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

Description:



This is a Sources Sought notice for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America-s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)-s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.



The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that are equal to the following product:



We are seeking a ExO-NET Pan-Exosome Capture Beads, 1.0mL: a magnetic bead-based immunoaffinity ev capture device, tool for exosome isolation from plasma, serum, urine, saliva and cell-conditioned medium. where a 3-dimensional antibody matrix is constructed on a carbon nanoparticle. The complement of antibodies attached to the bead has been designed to capture a

wide range of extracellular vesicles (EVs, including exosomes) from different cell types (pan-EV capture). ExO-NET is designed for On-Bead Analysis of captured nanoparticles and ON-Bead lysis for

downstream analysis of EV-associated molecules including proteins, oligonucleotides (mRNAs and microRNAs) and lipids. ExO-NET also can be tuned to preferentially isolate EVs from specific cell types. ExO-NET is a scalable EV isolation solution for high

throughput screening.



Product Composition

Component % (w/v):

Magnetic Beads 0.40%

Antibodies 0.05%

BS3 (bis(sulfosuccinimidyl)suberate) 0.07%

Proclin 3...
Active Contract Opportunity Notice ID SS-NIAID-24-2232555 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 19, 2024 05:37 pm EDT
Original Response Date: Jul 29, 2024 10:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Aug 13, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6509 - DRUGS AND BIOLOGICALS, VETERINARY USE
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Rockville, MD 20852 USA

Documents

 Tender Notice